Jcog0502 論文
Web1 feb 2024 · The results of the JCOG0502 trial, which is a parallel-group trial of esophagectomy versus CRT for patients with clinical Stage I esophageal carcinoma, have been reported recently [15]. Web日本消化器内視鏡学会雑誌, 2024 年 61 巻 Supplement1 号 p. 650-651
Jcog0502 論文
Did you know?
Web29 gen 2024 · 7 Background: Esophagectomy (E) is the standard of care for stage I esophageal squamous cell carcinoma (ESCC), while chemoradiotherapy (CRT) is a treatment option. A parallel-group controlled trial including randomized arms to confirm the non-inferiority of CRT to E for stage IA ESCC was conducted. Methods: Patients (pts) … WebBackground and aims: A drawback of endoscopic submucosal dissection (ESD) for early gastric cancer (EGC) is the development of metachronous gastric cancer (MGC). While MGC after ESD for differentiated-type (D-) EGC was well understood, little is known about MGC occurring after ESD for undifferentiated-type (UD-) EGC, because ESD had not …
WebBackground: Locally advanced gastric cancer with extensive regional and/or para-aortic lymph node (PAN) metastases is typically unresectable and associated with poor outcomes. This study investigated the safety and efficacy of S-1 plus cisplatin followed by extended surgery with PAN dissection for gastric cancer with extensive lymph node metastasis. Web5. 発表論文 1. Manabu Muto , Toshiro Iizuka 2. Chia-Hung Tu, , et al. Macroscopic Estimation of Submucosal Invasion in the Esophagus. Tec Gastrointest Endosc (in press) Manabu Muto, Keiko Minashi, Keiji Nihei 3. Reiko Akitake, Shin-ichi Miyamoto , , et al. Submucosal tumor
Web12 apr 2013 · Ken Kato, Takako Eguchi Nakajima, Yoshinori Ito, Chikatoshi Katada, Hiromichi Ishiyama, Shin-ya Tokunaga, Masahiro Tanaka, Shuichi Hironaka, Takayuki Hashimoto, Takashi Ura, Takeshi Kodaira, Ken-ichi Yoshimura, Phase II Study of Concurrent Chemoradiotherapy at the Dose of 50.4 Gy with Elective Nodal Irradiation for … WebBackground: In Japan, concurrent chemoradiotherapy is the standard treatment for unresectable esophageal cancer. The optimal combination of chemotherapeutic agents …
Web4 ago 2024 · JCOG0502 is a four-arm prospective study comparing esophagectomy with definitive chemo-radiotherapy. The use of thoracoscopy and/or laparoscopy was decided …
Web4 ago 2024 · JCOG0502 is a four-arm prospective study comparing esophagectomy with definitive chemo-radiotherapy. The use of thoracoscopy and/or laparoscopy was decided at the surgeon’s discretion. PPCs were defined as one or more of the following postoperative morbidities grade ≥2 (as per Common Terminology Criteria for Adverse Events v3.0): … boral outer wall 60Web4 No 158 Tumor location Upper 16 Middle 120 Lower 41 Macroscopic type 0-I 19 0-IIa 30 0-IIb 4 0-IIc 124 Clinical diagnosis of invasion boral one piece s tileWebjcog0502 を計画しました。 研究方法・成果 2 つの異なる治療をより正確に評価するため、臨床病期i 期の食道扁平上皮がん患者さんを、手術療 法群と化学放射線療法群とにラ … boral open cellWeb26 ott 2024 · To clarify whether thoracoscopic approach affected the incidence of cancer recurrence in the chest, we are now examining the first cancer recurrence site using data from JCOG0502 (JCOG0502-S8 study). The phase III trial (MIRO) has shown that the laparoscopic approach prevented postoperative complications and did not shorten long … haunted house burlington iowaWeb30 nov 2024 · JCOG食道がんグループでは、臨床病期I期の食道扁平上皮がん患者さんに対して、標準治療である手術療法と、食道切除を行わない化学放射線療法とを比較する … boral outrwallWeb1 feb 2024 · The results of the JCOG0502 trial, which is a parallel-group trial of esophagectomy versus CRT for patients with clinical Stage I esophageal carcinoma, … haunted house bulletin boardWeb12 apr 2013 · Ken Kato, Takako Eguchi Nakajima, Yoshinori Ito, Chikatoshi Katada, Hiromichi Ishiyama, Shin-ya Tokunaga, Masahiro Tanaka, Shuichi Hironaka, Takayuki … boral oto